Novel purine derivatives of formula
as agents for treating autoimmune diseases are described. Also disclosed are processes for their production and pharmaceutical compositions comprising the compounds, as well as novel intermediates in the manufacture thereof.
描述了新颖的式
嘌呤衍
生物
作为治疗自身免疫性疾病的药物。此外,还公开了其生产工艺和包含这些化合物的药物组合物,以及生产这些化合物的新型中间体。